Do antiplatelet drugs work the same in patients over 80? a study puts it to the test.
NCT ID NCT07724301
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This observational study examines how antiplatelet medications affect platelet function in people over 80 with atrial fibrillation who have received a Watchman implant. Researchers will measure various markers of platelet reactivity before and after treatment to see if clotting risk is adequately controlled in this older population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can closing a hole in the heart prevent future strokes? a long-term study seeks answers.
- Brain filter may prevent stroke during heart procedure
- Weight-Loss drug tirzepatide may help keep heart rhythm steady after ablation
- Simple changes to electrode placement could boost heart shock success
- Heart closure device put to the test: does it preserve heart function?
- Can smartphones and wearables unlock the secrets of atrial fibrillation?